Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.

Bone Marrow Transplant · 2023 · PMC10622316 · PMID 37626267

Europe PMC DOI

hedged sentences

0.2000

closest p · 4.0× alpha

0.3700

boldest claim

The sentences

did not reach statistical significancep = 0.20not close (p > 0.1)

There was a trend toward lower incidence of VTE events in the post-VPP group which did not reach statistical significance (8.6% vs. 6.0%, p = 0.20).

also in 33,519 other papers

a numerical trendp = 0.37not close (p > 0.1)

Similar to the results of the overall cohort, the allogeneic HCT subgroup demonstrated no difference in composite bleeding events or VTE events between the pre-VPP and post-VPP groups, though there was a numerical trend towards more bleeding events (18 (21.4%) vs. 24 (27.3%), p = 0.37) and less VTE events in the post-VPP group (8 (9.5%) vs. 4 (4.5%), p = 0.24) (Tables S 1 , S 2 ).

also in 268 other papers

an observed trendno p-value reported

There was an observed trend toward decreased incidence of VTE, though larger studies utilizing serial imaging to assess VTE will be required to confirm this benefit.

also in 199 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.